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Abstract
Introduction: Recently, red cell distribution width (RDW), a measure of erythrocyte size variability, has been shown
to be a prognostic marker in critical illness. The aim of this study was to investigate whether adding RDW has the
potential to improve the prognostic performance of the simplified acute physiology score (SAPS) to predict short-
and long-term mortality in an independent, large, and unselected population of intensive care unit (ICU) patients.
Methods: This observational cohort study includes 17,922 ICU patients with available RDW measurements from
different types of ICUs. We modeled the association between RDW and mortality by using multivariable logistic
regression, adjusting for demographic factors, comorbidities, hematocrit, and severity of illness by using the SAPS.
Results: ICU-, in-hospital-, and 1-year mortality rates in the 17,922 included patients were 7.6% (95% CI, 7.2 to 8.0),
11.2% (95% CI, 10.8 to 11.7), and 25.4% (95% CI, 24.8 to 26.1). RDW was significantly associated with in-hospital
mortality (OR per 1% increase in RDW (95%CI)) (1.14 (1.08 to 1.19), P < 0.0001), ICU mortality (1.10 (1.06 to 1.15), P
< 0.0001), and 1-year mortality (1.20 (95% CI, 1.14 to 1.26); P < 0.001). Adding RDW to SAPS significantly improved
the AUC from 0.746 to 0.774 (P < 0.001) for in-hospital mortality and 0.793 to 0.805 (P < 0.001) for ICU mortality.
Significant improvements in classification of SAPS were confirmed in reclassification analyses. Subgroups
demonstrated robust results for gender, age categories, SAPS categories, anemia, hematocrit categories, and renal
failure.
Conclusions: RDW is a promising independent short- and long-term prognostic marker in ICU patients and
significantly improves risk stratification of SAPS. Further research is needed the better to understand the
pathophysiology underlying these effects.
Introduction
Red cell distribution width (RDW) is a measure of ery-
throcyte size variability and has been shown to be a
prognostic marker for mortality, mainly in patients with
cardiovascular disease and in community-dwelling
patients, as well as in general in-hospital patients [1-16].
Although the mechanisms linking RDW to adverse
patient outcomes remain incompletely understood,
potential pathways include chronic inflammation
[17,18], malnutrition [9-11], and anemia of different
etiologies [19,20], among others. The prognostic poten-
tial of RDW is of particular interest because it is routi-
nely included in the automated complete blood count
(CBC) analyses in hospitalized patients and thus avail-
able at no additional cost for clinicians. Recent studies
have found RDW to be a prognostic marker for short-
and long-term mortality in critically ill patients [21-23].
The first study in critical illness was conducted in a
cohort of 602 patients in China and found that RDW is
associated with ICU mortality [22]. Recently, a large 10-
year retrospective study from two US centers validated
these findings and found RDW to be a robust predictor
of the risk of all-cause patient mortality and blood-
stream infection in the critically ill [21]. Finally, one
report found RDW to be a strong outcome predictor in
patients with pneumonia [23]. However, from these
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state-of-the-art risk prediction in unselected critically ill
patients.
We therefore aimed to investigate whether adding
RDW has the potential to improve the prognostic per-
formance of the Simplified Acute Physiology Score
(SAPS) to predict short- and long-term mortality in an
independent, large, and unselected population of ICU
patients.
Materials and methods
Data source
This observational study used the prospectively collected
Multiparameter Intelligent Monitoring in Intensive Care
(MIMIC II) database, a publicly available clinical data-
base developed by the Massachusetts Institute of Tech-
nology, Phillips Healthcare, and Beth Israel Deaconess
Medical Center (BIDMC) since 2001 [24]. This database
is a repository of de-identified physiologic, laboratory,
and survival outcome data from more than 30,000 criti-
cally ill patients treated in ICUs at BIDMC. These data
include clinical variables such as demographics (patient
age, gender), highly granular physiologic data captured
by the bedside monitors, medications administered and
procedures performed, chronic disease diagnoses as
represented by International Classification of Diseases
(ICD)-9 codes, as well as laboratory results, such as
complete blood count, serum chemistries, and microbio-
logic data. It further includes severity of illness, as
assessed with SAPS I, and survival data within both the
ICU and the hospital. The SAPS-I score was chosen in
MIMIC II for its simplicity, requiring only available clin-
ical laboratory measurements, fluid balance, and vital
signs [25]. Finally, survival outcome data after hospital
discharge is provided from the Social Security database.
Patients included in this analysis were hospitalized
between January 2001 and December 2008.
MIMIC II is a public de-identified ICU database that
was developed with funding from the National Institutes
of Health and the National Institute of Bio-imaging and
Bioengineering. The project had approval from by Insti-
tutional Review Boards of both Beth Israel Deaconess
Medical Center (Boston, MA, USA) and the Massachu-
setts Institute of Technology (Cambridge, MA, USA).
The requirement for individual patient consent was
waived because the study did not affect clinical care,
and all protected health information had been deleted.
Patients, outcomes, and covariates
We included all adult patients admitted to ICU floors
who had an RDW measured on admission. RDW is rou-
tinely measured in admitted patients reported on every
CBC and required no separate physician order. All
CBCs were conducted on Advia Equipment (Siemens,
models 2120 and 120). The normal reference range for
RDW at our center is 10.5% to 15.5%. The primary out-
come of interest was in-hospital mortality, defined as
death before hospital discharge for any reason. The sec-
ondary outcomes of interest were ICU mortality, defined
as death before ICU discharge and 1-year long-term
mortality. The primary predictor of interest was RDW
measured on ICU admission. We classified patients’
comorbidity status based on the method described by
Elixhauser et al. [26], as implemented by the Agency for
Healthcare Research and Quality Comorbidity Software
[27].
Statistical analysis
First, we used descriptive statistics including mean with
standard deviation and frequencies to describe the
population, as appropriate. Next, we investigated the
association between RDW used as a continuous variable
and mortality by using logistic regression analysis and
reported odds ratios (ORs) and 95% confidence intervals
(CIs). We conducted univariable analysis and a multi-
variable analysis adjusted for SAPS, age, gender, hemato-
crit, and different comorbidities (anemia, renal failure,
CHF, cardiac arrhythmias, valvular disease, chronic pul-
monary disease, lung embolism, pneumonia, peripheral
vascular disease, hypertension, paralysis, other neurolo-
gic diseases, diabetes, hypothyroidism, liver disease, pep-
tic ulcer, HIV, lymphoma, cancer, rheumatoid arthritis,
coagulopathy, obesity, weight loss, electrolyte distur-
bance, alcohol abuse, drug abuse, psychosis, and depres-
sion). To account for potential clustering within ICUs,
we performed hierarchic modeling with a generalized
estimating equation (GEE) by using an exchangeable
variance-covariance structure with compound symmetry.
Model discrimination was assessed by calculation of the
receiver-operating characteristic (ROC) curves and
reporting of the area under the curve (AUC). To assess
the fit of the GEE model, we used the Quasi-likelihood
under the Independence model Criterion (QIC) statistic,
as previously suggested [28]. We also tested for effect
modification by using interaction terms, to determine
whether the effect of RDW on mortality varied by
subgroups.
In addition to ROC analysis, we assessed the effect of
adding RDW to risk-adjusted models by using reclassifi-
cation-analysis methods, as suggested by Pencina [29].
Reclassification analysis is a more modern method that
is widely recommended for assessing the incremental
contribution of biomarkers to risk prediction. It is also
more intuitive than areas under the ROC curve: for
example, a net reclassification improvement (NRI) for
mortality of 10% means that 10% of patients are more
accurately classified by the new algorithm when com-
pared with the old. The analyses used continuous
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risk-category reclassification for survivors and nonsurvi-
vors. This approach separately analyzed the reclassifica-
tion of persons who died and those who did not die
during the ICU and hospital course. Reclassification to a
higher-risk group was considered upward movement in
classification for nonsurvivors. Conversely, reclassifica-
tion downward was considered a failure for nonsurvivors
and vice versa for survivors. Improvement in reclassifi-
cation was estimated by taking the sum of differences in
proportions of individuals reclassified upward minus the
proportion reclassified downward for nonsurvivors and
the proportion of individuals moving downward minus
the proportion moving upward for survivors. For esti-
mating meaningful ap r i o r imortality risk categories, we
defined probabilities for mortality as < 2%, 2% to 5%, >
5% to 10%, > 10% to 20%, > 20% to 50%, and > 50%.
We calculated the net reclassification improvement
(NRI), which assesses improvement in reclassification
over risk categories; we also assessed integrated discri-
mination improvement (IDI), which can be viewed as a
continuous version of the NRI without the recourse to a
priori defined risk categories.
All reported CIs are two-sided 95% intervals, and tests
were performed at the two-sided 5% significance level.
All analyses were performed with SAS 9.2.
Results
Population
We included a total of 17,922 patients admitted to one
of five ICUs into this analysis. The mean age of patients
was 63.2 years, and 57% were males. In total, 36% were
medical ICU patients, 26% were surgical ICU patients,
16% were in the cardiac care unit, and 21% were from
the cardiothoracic surgery unit. Baseline characteristics
of the study population are presented in Table 1. Mean
(standard deviation) RDW values in the overall cohort
were 14.6% (± 2.0%).
RDW and in-hospital and ICU mortality
The in-hospital mortality rate was 11.2% (95% CI, 10.8
to 11.7), and ICU mortality was 7.6% (95% CI, 7.2 to
8.0). For graphic display, we divided RDW into deciles
and plotted mortality within RDW deciles. Both in-hos-
pital and ICU mortality increased with increasing RDW
deciles, as displayed in Figure 1A and 1B (left panel).
In-hospital mortality was around 5% in the lowest three
deciles, increased to around 10% in deciles 4 to 7, and
was around 20% in the three highest deciles. Based on
this analysis, we defined three RDW categories: < 13.5%,
13.5% to 16.4%, and ≥16.5%, which approximately corre-
spond to tertiles and in which mortality was low, inter-
mediate, and high (Figure 1, right panel). Analyses
stratified by severity of illness showed that these
categories also predicted mortality rates within SAPS
quartiles (Figure 2).
Regression models for short-term mortality
With hierarchic modeling, we found that RDW used as
a continuous variable was significantly associated with
both in-hospital and ICU mortality. The association
remained significant after adjusting for SAPS, age,
Table 1 Characteristics of ICU cohort (n = 17,922)
Demographics
Age (year), mean, median (SD, IQR) 63.2, 65.2 (± 17.6, 51.3 to
77.6)
Female gender, n (%) 7,717 (43.10%)
Type of ICU, n (%)
Cardiac Care Unit 2,918 (16.28%)
Cardiothoracic Surgery Unit 3,824 (21.34%)
Medical Intensive Care Unit 6,536 (36.46%)
Surgical Intensive Care Unit 4,644 (25.91%)
Lab values on admission
Hematocrit (%), mean, median (SD, IQR) 32.3, 32.0 (± 5.6, 28.4 to
36.0)
SAPS on admission, mean, median (SD,
IQR)
13.6, 13.0 (± 5.5, 10.0 to
17.0)
Comorbidities, n (%)
Anemia 4,225 (23.57%)
Chronic renal failure 3,641 (20.32%)
Congestive heart failure 3,301 (18.42%)
Peripheral vascular disease 1,347 (7.52%)
COPD 2,820 (15.73%)
Any cancer 2,887 (16.10%)
Diabetes 4,071 (22.71%)
COPD, chronic obstructive pulmonary disease; IQR, interquartile range; SAPS,
Simplified Acute Physiology Score; SD, standard deviation.
Figure 1 Mortality. Hospital mortality (A) and ICU mortality (B)
within RDW deciles (left panel) and RDW categories (right panel).
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ing anemia, in a multivariable model (Table 2). Of
note, the odds ratio corresponds to a 1-unit (1%)
increase in RDW. In both models, RDW was a signifi-
cant outcome predictor independent of SAPS. We
further analyzed the association between RDW and
mortality in different predefined subgroups: gender,
different age categories, SAPS quartiles, anemia, hema-
tocrit quartiles, and renal failure. Figure 3 shows esti-
mates for the different subgroups. Of note, the results
proved to be robust across the different subgroups,
particularly also in anemia patients and patients with
different hematocrit values.
Effect on discrimination and reclassification
We also evaluated the incremental benefit of adding
RDW to SAPS by calculating AUCs and reclassification
statistics (Table 3). For in-hospital mortality, adding
RDW to SAPS improved the AUC from 0.746 to 0.774
(P < 0.001). Reclassification statistics showed a signifi-
cant improvement in NRI of 0.175 (P < 0.0001), corre-
sponding to a 17.5% improvement in classification of
patients. This was mainly due to better classification of
nonsurvivors into lower-risk classes. Detailed results of
reclassification tables are presented in Additional file 1
(hospital mortality) and Additional file 2 (ICU mortal-
ity). The results for ICU mortality were similar, and
adding RDW to SAPS improved the AUC from 0.793 to
0.805 (P < 0.001) (Table 3, right side). Reclassification
statistics showed an NRI 0.090 (P < 0.0001),
Figure 2 RDW categories (< 13.5%, 13.5% to 16.4%, ≥16.5%)
and mortality within SAPS subgroups.
Table 2 Results from regression analysis
In-hospital mortality ICU mortality
OR (95% CI) P OR (95% CI) P
Univariable
RDW per 1% increase 1.20 (1.16,
1.24)
<
0.0001
1.18 (1.14,
1.22)
<
0.0001
SAPS per 1-point
increase
1.19 (1.15,
1.23)
<
0.0001
1.21 (1.18,
1.25)
<
0.0001
Multivariable
RDW per 1% increase 1.14 (1.08,
1.19)
<
0.0001
1.10 (1.06,
1.15)
<
0.0001
SAPS per 1-point
increase
1.16 (1.13,
1.18)
<
0.0001
1.20 (1.18,
1.22)
<
0.0001
The multivariable hierarchic model is adjusted for age, gender, hematocrit,
and different comorbidities (anemia, renal failure, chronic heart failure, cardiac
arrhythmias, valvular disease, chronic pulmonary disease, lung embolism,
pneumonia, peripheral vascular disease, hypertension, paralysis, other
neurologic diseases, diabetes, hypothyroidism, liver disease, peptic ulcer, HIV,
lymphoma, cancer, rheumatoid arthritis, coagulopathy, obesity, weight loss,
electrolyte disturbance, alcohol abuse, drug abuse, psychosis, depression).
Figure 3 (A) Subgroup analysis for association of RDW and in-
hospital mortality. (B) Subgroup analysis for association of RDW
and ICU mortality.
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Adding RDW improved both the classification of non-
survivors into higher-risk classes and the classification
of survivors into lower-risk classes.
RDW and 1-year survival
Finally, we evaluated the prognostic value of RDW to
predict 1-year mortality within this ICU cohort. RDW
was significantly associated with 1-year mortality in our
multivariable adjusted model (OR, 1.20 (95% CI, 1.14 to
1.26); P < 0.001) and showed high discrimination of 1-
year survivors and nonsurvivors (AUC, 0.73; 95% CI,
0.72 to 0.74). Figure 4 shows a Kaplan-Meier plot
stratified by RDW quartiles to illustrate long-term survi-
val rates.
Discussion
In this large cohort of ICU patients, RDW strongly and
independently predicted hospital mortality, ICU mortal-
ity, and 1-year mortality. As evidenced by improvement
in both AUC and net reclassification index, RDW mate-
rially improved the prediction of mortality over and
above traditional severity of illness, as measured with
S A P S .T h i sf i n d i n gw a sr o b u s ta c r o s ss u b g r o u p s( f o r
example, different age and hematocrit categories and
comorbidities such as anemia or renal failure, factors
that are known to be positively associated with RDW
values [12,19,20]).
These results are in accordance with previous research
showing an association of RDW and long-term mortality
risks in different patient populations, such as patients
with cardiovascular disease, chronic heart failure, and
acute kidney injury treated with continuous renal-repla-
cement therapy [2-16,30]. Cohort studies using nation-
ally representative samples of the US population (Third
National Health and Nutrition Survey (NHANES III))
also reported an association of RDW with long-term
outcomes in community-dwelling patients [9-11]. In
addition, recent studies have focused on critically ill
patients and found RDW to be a prognostic in this set-
ting as well [21-23]. Importantly, our results based on a
broad US patient population admitted to different types
of ICUs, including medical, cardiac, surgical, and
Table 3 Reclassification results for in-hospital and ICU mortality
Hospital mortality ICU mortality
SAPS SAPS and
RDW
SAPS versus SAPS/
RDW
P SAPS SAPS and
RDW
SAPS versus SAPS/
RDW
P
Model c
2 (log likelihoods) 1,505 1,831 326 <
0.0001
1,539 1,664 124 <
0.0001
Area under the ROC curve 0.746 0.774 0.028 < 0.001 0.793 0.805 0.012 < 0.001
Events
Upward reclassification 362 197
No reclassification 1,214 947
Downward reclassification 309 153
No events
Upward reclassification 1,532 1,376
No reclassification 9,849 12,412
Downward reclassification 4,046 2257
Net reclassification improvement 0.175 (SE 0.015) <
0.0001
0.090 (SE 0.049) <
0.0001
Integrated sensitivity 0.20 0.23 0.021 <
0.0001
0.19 0.20 0.01 <
0.0001
Integrated specificity 0.099 0.096 -0.0026 <
0.0001
0.07 0.06 -0.0008 <
0.0001
Integrated discrimination
improvement
0.023 (SE 0.001) <
0.0001
0.011 (SE 0.001) <
0.0001
Figure 4 Kaplan-Meier plot for 1-year survival within RDW
quartiles (< 13.2%, 13.2% to 14.1%, 14.1% to 15.4%, and >
15.4%).
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vious findings and demonstrate that RDW is a strong
outcome predictor and thereby improves risk prediction
based on the well-established SAPS score. We found the
association of RDW and outcome to be robust when
focusing on hospital and 1-year mortality overall and in
different subgroups, such as patients with anemia.
Great interest is expressed in finding new prognostic
markers in critically ill patients in the ICU setting. Early
prognostication potentially helps to improve triage deci-
sions in terms of early discharge of patients, and also
with regard to therapeutic interventions. A prognostic
marker should be evaluated based on the information it
provides, beyond information already available based on
clinical information, such as the information incorpo-
rated in SAPS. The SAPS system was developed to mea-
sure severity of illness in ICU patients, and subsequent
research has validated its use to predict outcome in ICU
patients [31]. Within our large sample, SAPS showed
reasonable discrimination with AUCs between 0.75 and
0.80. Still, adding RDW to the SAPS further improved
its discriminatory ability for both hospital mortality and
ICU mortality. This was further confirmed when calcu-
lating reclassification statistics. For in-hospital mortality,
this was mainly due to better classification of nonsurvi-
vors into lower-risk classes, whereas for ICU mortality,
RDW improved classification of survivors and nonsurvi-
vors. Importantly, from a cost perspective, it should be
noted that RDW is routinely measured in most patients
as part of the admission CBC analysis and thus is free
of additional costs. It will important for future studies
to assess whether more-advanced severity of illness
scores (that is, APACHE IV, SAPS III) can still be
improved by the addition of RDW.
Our results provide an important target for future
translational research. Why is RDW associated with
increased mortality? The underlying mechanism is still
unclear and represents an important avenue for future
“bedside-to-bench” research. RDW can be increased in
anemia or hemoglobinopathies, hemolysis, or after blood
transfusions [19,20]. Yet, in our study and in the litera-
ture, the association of RDW and mortality was inde-
pendent of anemia, and no evidence was found for
effect modification by anemia and hematocrit levels
[9-11,13]. Another possible pathophysiologic explanation
is that RDW is a surrogate of inflammation, which is
known to increase RDW. Several studies found RDW to
be associated with blood markers of inflammation, such
as interleukin-6, C-reactive protein (CRP) [11], as well
as impaired iron mobilization [17]. Also, oxidative stress
has been shown to increase anisocytosis by disrupting
erythropoiesis, and to alter blood cell membrane
deformability and red blood cell circulation half-life,
ultimately leading to increased RDW [9,11,19]. Again,
previous research found that adjusting for inflammation
(for example, CRP) did not substantially reduce the
prognostic value of RDW, demonstrating its effect
beyond these factors [9-11,22]. In our cohort, we were
not able to adjust the analysis for inflammatory markers,
as these are not routinely measured on admission.
RDW may also reflect the patient’s degree of physiolo-
gical reserve, one of three main determinants of clinical
outcome, as suggested by Bion [32]. The physiological
reserve represents cellular response to acute stress and
the resultant tissue hypoxia. Ischemia activates cellular
systems that would reduce oxygen demand and physio-
logic processes that would improve tissue oxygen deliv-
ery, such as increased production and release of mature
red cells into the peripheral bloodstream. How well this
process of reactive erythropoiesis is carried out under
oxidative stress may represent the patient’s ability to
handle acute physiological insult. Release of large imma-
ture red cells with poor oxygen-binding capacity, which
results in an increased RDW, implies suboptimal
response to oxidative stress. This may explain why the
association between RDW and clinical outcome is inde-
pendent of the severity of acute illness as well as the
degree of inflammation. It may well represent the
genetic factors that determine how well the body with-
stands physiological stress, whether from a severe infec-
tion, multitrauma, burns, or acute pancreatitis.
S t r e n g t h so ft h i ss t u d ya r et h el a r g en u m b e ro f
patients across different types of ICUs and the availabil-
ity of a rich annotation of the physiological and clinical
context, which allowed rigorous adjustment for severity
of acute illness and subgroup analyses with high statisti-
cal power. We also included 1-year survival data on all
the patients.
This study has limitations; as it was a retrospective,
observational study, we were not able to assess causes
for mortality and/or for elevated RDW. Also, our data
provide no additional information about inflammation
and oxidative stress. These pieces of information
would be necessary to understand better the patho-
physiology underlying the observed effects. Also, only
admission RDW levels were considered, and it remains
unclear whether changes over time of RDW may pro-
vide additional prognostic information. Importantly,
we used SAPS, and more recent severity-of-illness
scores (such as SAPS III or APACHE IV) have shown
superior accuracy for outcome prediction; thus, future
studies should address whether RDW has the potential
also to improve these severity-of-illness scores. We
calculated multivariable regression models, including
important demographics and different comorbidities,
to investigate the independent association of RDW
and outcome; yet, co-linearity and missing clinical
information on some important patient-history items
Hunziker et al. Critical Care 2012, 16:R89
http://ccforum.com/content/16/3/R89
Page 6 of 8(that is, transfusion) may limit the interpretation of
the models.
Conclusions
This analysis validated previous studies and found RDW
to be a promising independent short- and long-term
prognostic marker in ICU patients, which significantly
improved the SAPS for risk stratification of patients.
This was also true within several subgroups, including
patients with anemia. If confirmed in future studies and
with updated severity-of-illness scores (such as SAPS III
or APACHE IV), RDW may help to improve current
prediction scores at little or no additional costs for
improved decision-making in ICU patients. Further stu-
dies should be conducted to understand better the
mechanism linking RDW to these adverse outcomes.
Key messages
￿ Red cell distribution width (RDW), a measure of
erythrocyte size variability, is a promising indepen-
dent short- and long-term prognostic marker in ICU
patients
￿ In this large U.S. cohort study including 17,922
patients from different types of ICUs, RDW was a
strong and independent outcome predictor for ICU-,
in-hospital, and 1-year mortality
￿ RDW further improved the prognostic accuracy of
the SAPS score
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